维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Tenen"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Enhancement of Hematopoietic Stem Cell Repopulating Capacity and Self-Renewal in the Absence of the Transcription Factor C/EBPα显示文摘	Pu Zhang Junko Iwasaki-Arai Hiromi Iwasaki Maris L. Fenyus Tajhal Dayaram Bronwyn M. Owens Hirokazu Shigematsu Elena Levantini Claudia S. Huettner Julie A. Lekstrom-Himes Koichi Akashi Daniel G. Tenen	2004	Immunity2004，，6：	2
2	Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells 显示文摘	Simmons DL Sarterthwaite AB Tenene DG	1992	Immunology1992，148，1：	1
3	Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-muta- ted lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations显示文摘	Costa DB Schumer ST Tenen DG	2008	J Clin Oncol2008，26，：	1
4	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers 显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
5	RNA editome imbalance in hepatocellular carcinoma显示文摘	Qi L Chan TH Tenen DG	2014	Cancer Res2014，74，5：	1
6	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR- mutant non-small cell lung cancers显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
7	Pooled analysis of the pr- ospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
8	Down regulation of PSA by C/EBPc is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell Line显示文摘	Yin H Radomska H S Tenen D G	2006	BMC Cancer2006，6，1：	1
9	RNA editome imbalance in hepato-cellular carcinoma显示文摘	Qi L Chan TH Tenen DG	2014	Cancer Res2014，74，5：	1
10	Antiamphetamine effects fol- lowing inhibition of tyrosine hydroxylase 显示文摘	Weissman A Koe B K Tenen S S	1996	J Pharmacol Exp T- her1996，151，3：	1
11	Transcription factors, normal myeloid development, and leukemia 显示文摘	Tenen DG Hromas R Licht JD	1997	Blood1997，90，2：	1
12	Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations 显示文摘	Costa DB Schumer ST Tenen DG	2008	J Clin Oncol2008，26，7：	1
13	RNA editome imbalance in hepatocellular carcinoma显示文摘	Qi L Chan TH Tenen DG	2014	Cancer Res2014，74，5：	1
14	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers显示文摘	Costa D B Kobayashi S Tenen D G	2007	Lung Cancer2007，58，1：	1
15	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
16	Differential responses to erlotinib in epidermal growth factor receptor (EGFR)-mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations显示文摘	Costa DB Schumer ST Tenen DG	2008	J Clin Oncol2008，26，7：	1
17	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non- small cell lung cancers 显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1
18	Disruption of differentiation in human cancer: AML shows the way显示文摘	Tenen DG	2003	Nat Rev Cancer2003，3，2：	1
19	Differential responses to erlotinib in epidermal growth factor receptor (EGFR) -mutated lung cancers with acquired resistance to gefitinib carrying the L747S or T790M secondary mutations显示文摘	Costa DB Schumer ST Tenen DG	2008	J Clin Oncol2008，26，7：	1
20	Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non- small cell lung cancers 显示文摘	Costa DB Kobayashi S Tenen DG	2007	Lung Cancer2007，58，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示